Results 141 to 149 of about 5,620 (149)
Some of the next articles are maybe not open access.
Journal of Neurosurgery
OBJECTIVE The objective was to comprehensively investigate the clinical, molecular, and imaging characteristics and outcomes of H3 K27–altered diffuse midline glioma (DMG) in adults. METHODS Retrospective chart and imaging reviews were performed in 111 adult patients with H3 K27–altered DMG from two tertiary institutions.
Yongsik, Sim +10 more
openaire +2 more sources
OBJECTIVE The objective was to comprehensively investigate the clinical, molecular, and imaging characteristics and outcomes of H3 K27–altered diffuse midline glioma (DMG) in adults. METHODS Retrospective chart and imaging reviews were performed in 111 adult patients with H3 K27–altered DMG from two tertiary institutions.
Yongsik, Sim +10 more
openaire +2 more sources
Neuroradiology
To investigate prognostic markers for H3 K27-altered diffuse midline gliomas (DMGs) in adults with clinical, qualitative and quantitative imaging phenotypes, including tumor oxygenation characteristics.Retrospective chart and imaging reviews were conducted on 32 adults with H3 K27-altered DMGs between 2017 and 2023.
Yongsik Sim +10 more
openaire +2 more sources
To investigate prognostic markers for H3 K27-altered diffuse midline gliomas (DMGs) in adults with clinical, qualitative and quantitative imaging phenotypes, including tumor oxygenation characteristics.Retrospective chart and imaging reviews were conducted on 32 adults with H3 K27-altered DMGs between 2017 and 2023.
Yongsik Sim +10 more
openaire +2 more sources
Neuro-Oncology
Abstract The blood–tumor barrier (BTB) among malignant glioma selectively hinders therapy exposure and distribution. The Wnt/β-catenin signaling pathway ensures high BTB integrity and promotes glioma stemness. We hypothesize that transduction of H3 K27-altered glioma stem cells with overexpressing Wnt/β-catenin inhibitors will enhance
Sadhana Jackson +3 more
openaire +1 more source
Abstract The blood–tumor barrier (BTB) among malignant glioma selectively hinders therapy exposure and distribution. The Wnt/β-catenin signaling pathway ensures high BTB integrity and promotes glioma stemness. We hypothesize that transduction of H3 K27-altered glioma stem cells with overexpressing Wnt/β-catenin inhibitors will enhance
Sadhana Jackson +3 more
openaire +1 more source
ISMRM Annual Meeting
Motivation: The prognostic markers of H3 K27-altered diffuse midline gliomas (DMGs) in adults have yet to be studied. Goal(s): To investigate prognostic markers for H3 K27-altered DMGs in adults, including clinical, qualitative, quantitative imaging phenotypes, and tumor oxygenation characteristics.
Yongsik Sim +3 more
openaire +1 more source
Motivation: The prognostic markers of H3 K27-altered diffuse midline gliomas (DMGs) in adults have yet to be studied. Goal(s): To investigate prognostic markers for H3 K27-altered DMGs in adults, including clinical, qualitative, quantitative imaging phenotypes, and tumor oxygenation characteristics.
Yongsik Sim +3 more
openaire +1 more source
Neuro-Oncology
Abstract H3 K27-altered spinal cord diffuse midline glioma (H3-SCDMG) represents a challenging malignancy with limited treatment options and experiment models. This study aimed to investigate novel therapeutic strategies for H3-SCDMG by leveraging the tumor’s biological characteristics and newly established experiment models ...
Ruichao Chai +4 more
openaire +1 more source
Abstract H3 K27-altered spinal cord diffuse midline glioma (H3-SCDMG) represents a challenging malignancy with limited treatment options and experiment models. This study aimed to investigate novel therapeutic strategies for H3-SCDMG by leveraging the tumor’s biological characteristics and newly established experiment models ...
Ruichao Chai +4 more
openaire +1 more source
Video of the segmented tumor in a 14-year-old girl with DMG, H3 K27-altered.
ASVIDE, 2022Baolian Zhao +6 more
openaire +1 more source
Incidental Diffuse Midline Glioma, H3 K27-Altered of the Pons Without Significant Coalterations
JCO Precision OncologyKee Kiat Yeo +7 more
openaire +1 more source

